| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Sensei Biotherapeutics, Inc. (SNSE) has 9 insiders with recent SEC Form 4 filings, including 16 buys and 0 sells. SNSE is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| COO | 1.24M | $29.00M | - | |
| ? | 155.6K | $3.64M | - | |
| Other | 80.0K | $1.87M | - | |
| Dir | 23.1K | $540.5K | - | |
| Dir | 19.0K | $444.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 5, 2021 | Peyer James | Director, 10% Owner | Buy | 8,000 | $13.75 | $110,000.00 | +0.2% | |
| Mar 5, 2021 | Cambrian Biopharma Inc | 10% Owner | Buy | 8,000 | $13.75 | $110,000.00 | +0.2% | |
| Mar 4, 2021 | Cambrian Biopharma Inc | 10% Owner | Buy | 5,000 | $15.16 | $75,800.00 | - | |
| Mar 4, 2021 | Peyer James | Director, 10% Owner | Buy | 5,000 | $15.16 | $75,800.00 | - | |
| Mar 2, 2021 | Cambrian Biopharma Inc | 10% Owner | Buy | 3,000 | $16.25 | $48,750.00 | - | |
| Mar 2, 2021 | Peyer James | Director, 10% Owner | Buy | 3,000 | $16.25 | $48,750.00 | - | |
| Feb 26, 2021 | Peyer James | Director, 10% Owner | Buy | 5,000 | $16.25 | $81,250.00 | +0.1% | |
| Feb 26, 2021 | Cambrian Biopharma Inc | 10% Owner | Buy | 5,000 | $16.25 | $81,250.00 | +0.1% | |
| Feb 25, 2021 | Peyer James | Director, 10% Owner | Buy | 31,000 | $16.48 | $510,862.00 | +0.2% | |
| Feb 25, 2021 | Cambrian Biopharma Inc | 10% Owner | Buy | 31,000 | $16.48 | $510,862.00 | +0.2% |